Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis.

Enrico De LorenzisAdi MorRebecca L RossStefano Di DonatoRevital ArichaIlan VakninFrancesco Del Galdo

Published in: Arthritis care & research (2024)

Serum CCL24 is a biomarker of disease severity across fibrotic and vascular disease manifestations. These data support the development of therapies targeting CCL24 as a novel comprehensive therapeutic target in SSc.

Keyphrases

systemic sclerosis
interstitial lung disease
liver fibrosis
liver injury
drug induced
electronic health record
idiopathic pulmonary fibrosis
cancer therapy
big data
rheumatoid arthritis
artificial intelligence
data analysis